XORTX Therapeutics Inc. (XRTX) Q3 2024 Earnings
XRTX·Reported November 14, 2024·After market close
Diluted EPS came in at $-0.20, beat the $-0.38 consensus by $0.18.
Diluted EPS
$-0.20beat by $0.18
Consensus: $-0.38
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about XORTX Therapeutics Inc.'s Q3 2024 earnings report.
XORTX Therapeutics Inc. (XRTX) reported Q3 2024 earnings on November 14, 2024 after market close.
XORTX Therapeutics Inc. reported diluted EPS of $-0.20 for Q3 2024.
EPS beat the consensus estimate of $-0.38 by $0.18.